179 related articles for article (PubMed ID: 210500)
1. Trisodium phosphonoformate, a new antiviral compound.
Helgstrand E; Eriksson B; Johansson NG; Lannerö B; Larsson A; Misiorny A; Norén JO; Sjöberg B; Stenberg K; Stening G; Stridh S; Oberg B
Science; 1978 Sep; 201(4358):819-21. PubMed ID: 210500
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
Oberg B
Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
[No Abstract] [Full Text] [Related]
3. Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs.
Alenius S; Dinter Z; Oberg B
Antimicrob Agents Chemother; 1978 Sep; 14(3):408-13. PubMed ID: 213015
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.
Reno JM; Lee LF; Boezi JA
Antimicrob Agents Chemother; 1978 Feb; 13(2):188-92. PubMed ID: 206200
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
Alenius S
Arch Virol; 1980; 65(2):149-56. PubMed ID: 6252867
[TBL] [Abstract][Full Text] [Related]
6. Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates.
Frank KB; Cheng YC
Antimicrob Agents Chemother; 1985 Apr; 27(4):445-8. PubMed ID: 2988429
[TBL] [Abstract][Full Text] [Related]
7. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
Oberg B
Pharmacol Ther; 1989; 40(2):213-85. PubMed ID: 2543994
[TBL] [Abstract][Full Text] [Related]
8. Experimental studies on the antiherpetic agent phosphonoformic acid.
Helgstrand E; Oberg B; Alenius S
Adv Ophthalmol; 1979; 38():276-80. PubMed ID: 230720
[No Abstract] [Full Text] [Related]
9. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K
Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189
[TBL] [Abstract][Full Text] [Related]
10. Pyrophosphate analogues as inhibitors of DNA polymerases of cytomegalovirus, herpes simplex virus and cellular origin.
Eriksson B; Oberg B; Wahren B
Biochim Biophys Acta; 1982 Feb; 696(2):115-23. PubMed ID: 6277381
[TBL] [Abstract][Full Text] [Related]
11. [Antiviral activity of phosphonoacetic acid, phosphonopropionic acid, and trisodium phosphonoformate hexahydrate against herpesvirus hominis type 1 and type 2 in vitro].
Thiel KD; Wutzler P; Sprössig M; Bertram D
Pharmazie; 1982 Aug; 37(8):608. PubMed ID: 6292963
[No Abstract] [Full Text] [Related]
12. Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate.
Eriksson B; Oberg B
Antimicrob Agents Chemother; 1979 Jun; 15(6):758-62. PubMed ID: 475360
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effect of trisodium phosphonoformate on the mean plaque size of pseudorabies virus, infectious bovine rhinotracheitis virus and pigeon herpesvirus.
Schwers A; Pastoret PP; Vindevogel H; Leroy P; Aguilar-Setien A; Godart M
J Comp Pathol; 1980 Oct; 90(4):625-33. PubMed ID: 6268670
[No Abstract] [Full Text] [Related]
14. Trisodium phosphonoformate inhibits woodchuck hepatitis virus associated DNA polymerase.
Nordenfelt E; Werner B
Acta Pathol Microbiol Scand B; 1980 Jun; 88(3):183-4. PubMed ID: 6449828
[TBL] [Abstract][Full Text] [Related]
15. Effect of trisodium phosphonoformate and idoxuridine on experimental herpes simplex keratitis in immunized and non-immunized rabbits.
Alenius S; Laurent U; Oberg B
Acta Ophthalmol (Copenh); 1980 Apr; 58(2):167-73. PubMed ID: 6249066
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of foscarnet against viral polymerases.
Crumpacker CS
Am J Med; 1992 Feb; 92(2A):3S-7S. PubMed ID: 1371038
[TBL] [Abstract][Full Text] [Related]
17. The antiherpesvirus action of phosphonoacetate.
Boezi JA
Pharmacol Ther; 1979; 4(1):231-43. PubMed ID: 88744
[No Abstract] [Full Text] [Related]
18. Inhibition of herpes simplex virus infection in tissue culture by trisodium phosphonoformate.
Svennerholm B; Vahlne A; Lycke E
Proc Soc Exp Biol Med; 1979 Jun; 161(2):115-8. PubMed ID: 221930
[No Abstract] [Full Text] [Related]
19. Antiviral potential of phosphonoacetic acid.
Overby LR; Duff RG; Mao JC
Ann N Y Acad Sci; 1977 Mar; 284():310-20. PubMed ID: 212978
[TBL] [Abstract][Full Text] [Related]
20. Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.
Smith KO; Galloway KS; Ogilvie KK; Cheriyan UO
Antimicrob Agents Chemother; 1982 Dec; 22(6):1026-30. PubMed ID: 6297382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
